270 related articles for article (PubMed ID: 17403661)
1. NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation.
de Frutos S; Spangler R; Alò D; Bosc LV
J Biol Chem; 2007 May; 282(20):15081-9. PubMed ID: 17403661
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries.
de Frutos S; Diaz JM; Nitta CH; Sherpa ML; Bosc LV
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C441-50. PubMed ID: 21525433
[TBL] [Abstract][Full Text] [Related]
3. NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal mice.
Bierer R; Nitta CH; Friedman J; Codianni S; de Frutos S; Dominguez-Bautista JA; Howard TA; Resta TC; Bosc LV
Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L872-80. PubMed ID: 21908592
[TBL] [Abstract][Full Text] [Related]
4. NFATc3 is required for intermittent hypoxia-induced hypertension.
de Frutos S; Duling L; Alò D; Berry T; Jackson-Weaver O; Walker M; Kanagy N; González Bosc L
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2382-90. PubMed ID: 18359899
[TBL] [Abstract][Full Text] [Related]
5. NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.
de Frutos S; Caldwell E; Nitta CH; Kanagy NL; Wang J; Wang W; Walker MK; Gonzalez Bosc LV
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H356-63. PubMed ID: 20495147
[TBL] [Abstract][Full Text] [Related]
6. NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
Szema AM; Forsyth E; Ying B; Hamidi SA; Chen JJ; Hwang S; Li JC; Sabatini Dwyer D; Ramiro-Diaz JM; Giermakowska W; Gonzalez Bosc LV
PLoS One; 2017; 12(1):e0170606. PubMed ID: 28125639
[TBL] [Abstract][Full Text] [Related]
7. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.
de Frutos S; Nitta CH; Caldwell E; Friedman J; González Bosc LV
Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L475-86. PubMed ID: 19592461
[TBL] [Abstract][Full Text] [Related]
8. ASIC1-mediated calcium entry stimulates NFATc3 nuclear translocation via PICK1 coupling in pulmonary arterial smooth muscle cells.
Gonzalez Bosc LV; Plomaritas DR; Herbert LM; Giermakowska W; Browning C; Jernigan NL
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L48-58. PubMed ID: 27190058
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
10. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.
Nilsson-Berglund LM; Zetterqvist AV; Nilsson-Ohman J; Sigvardsson M; González Bosc LV; Smith ML; Salehi A; Agardh E; Fredrikson GN; Agardh CD; Nilsson J; Wamhoff BR; Hultgårdh-Nilsson A; Gomez MF
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):218-24. PubMed ID: 19965778
[TBL] [Abstract][Full Text] [Related]
12. NFATc3 pathway participates in the process that 15-LO/15-HETE protects pulmonary artery smooth muscle cells against apoptosis during hypoxia.
Ran Y; Wu H; Wei L; Yu X; Chen J; Li S; Zhang L; Lou J; Zhu D
J Recept Signal Transduct Res; 2014 Aug; 34(4):270-82. PubMed ID: 24853029
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑153 attenuates hypoxia‑induced excessive proliferation and migration of pulmonary arterial smooth muscle cells by targeting ROCK1 and NFATc3.
Zhao M; Wang W; Lu Y; Wang N; Kong D; Shan L
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495839
[TBL] [Abstract][Full Text] [Related]
14. NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.
Ramiro-Diaz JM; Nitta CH; Maston LD; Codianni S; Giermakowska W; Resta TC; Gonzalez Bosc LV
Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(9):L613-25. PubMed ID: 23475768
[TBL] [Abstract][Full Text] [Related]
15. β1-Subunit of the calcium-sensitive potassium channel modulates the pulmonary vascular smooth muscle cell response to hypoxia.
Barnes EA; Lee L; Barnes SL; Brenner R; Alvira CM; Cornfield DN
Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L265-L275. PubMed ID: 29644895
[TBL] [Abstract][Full Text] [Related]
16. Silencing of STIM1 attenuates hypoxia-induced PASMCs proliferation via inhibition of the SOC/Ca2+/NFAT pathway.
Hou X; Chen J; Luo Y; Liu F; Xu G; Gao Y
Respir Res; 2013 Jan; 14(1):2. PubMed ID: 23289723
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells.
Kang K; Peng X; Zhang X; Wang Y; Zhang L; Gao L; Weng T; Zhang H; Ramchandran R; Raj JU; Gou D; Liu L
J Biol Chem; 2013 Aug; 288(35):25414-25427. PubMed ID: 23853098
[TBL] [Abstract][Full Text] [Related]
18. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
19. Actin polymerization contributes to enhanced pulmonary vasoconstrictor reactivity after chronic hypoxia.
Weise-Cross L; Sands MA; Sheak JR; Broughton BRS; Snow JB; Gonzalez Bosc LV; Jernigan NL; Walker BR; Resta TC
Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1011-H1021. PubMed ID: 29373038
[TBL] [Abstract][Full Text] [Related]
20. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
